Alyeska Investment Group’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-15,000	Closed	-$1.03M	–	563
2014 Q3	$1.03M	Buy	+15,000	New	+$1.03M	0.02%	307
2014 Q2	–	Sell	-14,249	Closed	-$1.18M	–	450
2014 Q1	$1.18M	Buy	+14,249	New	+$1.18M	0.03%	241